Literature DB >> 19233785

Cytokine and acute phase protein gene expression in repeated liver biopsies of dairy cows with a lipopolysaccharide-induced mastitis.

L Vels1, C M Røntved, M Bjerring, K L Ingvartsen.   

Abstract

A minimally invasive liver biopsy technique was tested for its applicability to study the hepatic acute phase response (APR) in dairy cows with Escherichia coli lipopolysaccharide (LPS)-induced mastitis. The hepatic mRNA expression profiles of the inflammatory cytokines, tumor necrosis factor alpha (TNF-alpha), IL-1beta, IL-6, and IL-10, and the acute phase proteins serum amyloid A isoform 3 (SAA3), haptoglobin (Hp), and alpha(1)-acid glycoprotein (AGP) were determined by real-time reverse transcription-PCR. Fourteen primiparous cows in mid lactation were challenged with 200 microg of LPS (n = 8) or NaCl solution (n = 6) in 1 front quarter. Six repeated liver biopsies were collected at -22, 3, 6, 9, 12, and 48 h relative to LPS challenge in 4 LPS-infused cows and 3 NaCl-infused cows. The remaining cows had 3 liver biopsies taken at -22, 9, and 48 h. Production data and clinical signs were recorded and white blood cell counts and somatic cell counts (SCC) were analyzed to investigate the effect of repeated liver biopsies and verify the LPS model. Plasma concentrations of TNF-alpha, SAA3, Hp, and AGP were determined for comparison with the liver expression data. Repeated liver biopsies had no effects on the production data, clinical signs, or APR of dairy cows. Compared with the NaCl-infused cows the LPS-infused cows responded to the LPS treatment by increased body temperature (38.6 +/- 0.1 vs. 39.4 +/- 0.1 degrees C), short-term leukopenia followed by leukocytosis (6.44 +/- 0.4 vs. 5.69 +/- 0.3 x 10(6) cells/mL), an increased SCC (log(10) 2.1 +/- 0.1 vs. log(10) 2.8 +/- 0.1 x 10(3) cells/mL), heart rate (76 +/- 1 vs. 93 +/- 1 beats/min), and respiratory rate (32 +/- 2 vs. 36 +/- 1 breaths/min) in the acute phase of the disease. The LPS treatment upregulated the hepatic expression of TNF-alpha (103 +/- 24 vs. 255 +/- 18 units), IL-1beta (37 +/- 23 vs. 296 +/- 18 units), IL-6 (8 +/- 17 vs. 122 +/- 12 units), and IL-10 (130 +/- 66 vs. 541 +/- 50 units), and SAA3 (64 +/- 36 vs. 128 +/- 28 units) and Hp (9 +/- 82 vs. 762 +/- 65 units) reaching maximum levels at 3 to 6 h and 9 to 12 h postinfusion, respectively. Plasma concentrations of TNF-alpha (nondetectable vs. 1.9 +/- 0.3 ng/mL), SAA (19.8 +/- 19.4 vs. 149.7 +/- 15.5 microg/mL) and Hp (71.4 +/- 143.7 vs. 1,013.8 +/- 111.5 microg/mL) were elevated in the LPS-infused cows at 4 to 12 h, 8 to 120 h, and 24 to 120 h postinfusion, respectively. The hepatic expression of AGP and the AGP plasma concentration remained unaltered in LPS-induced cows. In conclusion, a minimally invasive liver biopsy technique can be used for studying the hepatic APR in diseased cattle. Lipopolysaccharide-induced mastitis resulted in a time-dependent production of inflammatory cytokines and SAA and Hp in the liver of dairy cows.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233785     DOI: 10.3168/jds.2008-1209

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  34 in total

1.  Selected reaction monitoring mass spectrometry of mastitis milk reveals pathogen-specific regulation of bovine host response proteins.

Authors:  Ulrike Kusebauch; Lorenzo E Hernández-Castellano; Stine L Bislev; Robert L Moritz; Christine M Røntved; Emøke Bendixen
Journal:  J Dairy Sci       Date:  2018-04-11       Impact factor: 4.034

Review 2.  Functional adaptations of the transcriptome to mastitis-causing pathogens: the mammary gland and beyond.

Authors:  Juan J Loor; Kasey M Moyes; Massimo Bionaz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

3.  Patchouli alcohol dampens lipopolysaccharide induced mastitis in mice.

Authors:  Yong-Ping Li; Shi-Fang Yuan; Guo-Hong Cai; Hui Wang; Ling Wang; Lei Yu; Rui Ling; Jun Yun
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

4.  In depth analysis of genes and pathways of the mammary gland involved in the pathogenesis of bovine Escherichia coli-mastitis.

Authors:  Bart Buitenhuis; Christine M Røntved; Stefan M Edwards; Klaus L Ingvartsen; Peter Sørensen
Journal:  BMC Genomics       Date:  2011-02-28       Impact factor: 3.969

5.  Changes in thermal nociceptive responses in dairy cows following experimentally induced Escherichia coli mastitis.

Authors:  Ditte B Rasmussen; Katrine Fogsgaard; Christine M Røntved; Ilka C Klaas; Mette S Herskin
Journal:  Acta Vet Scand       Date:  2011-05-18       Impact factor: 1.695

6.  Lipopolysaccharide derived from the rumen down-regulates stearoyl-CoA desaturase 1 expression and alters fatty acid composition in the liver of dairy cows fed a high-concentrate diet.

Authors:  Tianle Xu; Hui Tao; Guangjun Chang; Kai Zhang; Lei Xu; Xiangzhen Shen
Journal:  BMC Vet Res       Date:  2015-03-07       Impact factor: 2.741

7.  Feeding a high-grain diet reduces the percentage of LPS clearance and enhances immune gene expression in goat liver.

Authors:  Guangjun Chang; Kai Zhang; Tianle Xu; Di Jin; Hans-Martin Seyfert; Xiangzhen Shen; Su Zhuang
Journal:  BMC Vet Res       Date:  2015-03-18       Impact factor: 2.741

8.  Acute mammary and liver transcriptome responses after an intramammary Escherichia coli lipopolysaccharide challenge in postpartal dairy cows.

Authors:  Andrea Minuti; Zheng Zhou; Daniel E Graugnard; Sandra L Rodriguez-Zas; Alejandro R Palladino; Felipe C Cardoso; Erminio Trevisi; Juan J Loor
Journal:  Physiol Rep       Date:  2015-04

9.  Neutrophil recruitment in endotoxin-induced murine mastitis is strictly dependent on mammary alveolar macrophages.

Authors:  Sharon Elazar; Erez Gonen; Ayala Livneh-Kol; Ilan Rosenshine; Nahum Yehuda Shpigel
Journal:  Vet Res       Date:  2009-10-14       Impact factor: 3.683

10.  Gene expression profiling of liver from dairy cows treated intra-mammary with lipopolysaccharide.

Authors:  Li Jiang; Peter Sørensen; Christine Røntved; Lotte Vels; Klaus L Ingvartsen
Journal:  BMC Genomics       Date:  2008-09-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.